Cargando…

Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells

Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive osteogenic transformation of vascular smooth muscle cells (VSMCs). We show that even in absence of exogenous aldoster...

Descripción completa

Detalles Bibliográficos
Autores principales: Alesutan, Ioana, Voelkl, Jakob, Feger, Martina, Kratschmar, Denise V., Castor, Tatsiana, Mia, Sobuj, Sacherer, Michael, Viereck, Robert, Borst, Oliver, Leibrock, Christina, Gawaz, Meinrad, Kuro-o, Makoto, Pilz, Stefan, Tomaschitz, Andreas, Odermatt, Alex, Pieske, Burkert, Wagner, Carsten A., Lang, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435689/
https://www.ncbi.nlm.nih.gov/pubmed/28515448
http://dx.doi.org/10.1038/s41598-017-01882-2
_version_ 1783237253691080704
author Alesutan, Ioana
Voelkl, Jakob
Feger, Martina
Kratschmar, Denise V.
Castor, Tatsiana
Mia, Sobuj
Sacherer, Michael
Viereck, Robert
Borst, Oliver
Leibrock, Christina
Gawaz, Meinrad
Kuro-o, Makoto
Pilz, Stefan
Tomaschitz, Andreas
Odermatt, Alex
Pieske, Burkert
Wagner, Carsten A.
Lang, Florian
author_facet Alesutan, Ioana
Voelkl, Jakob
Feger, Martina
Kratschmar, Denise V.
Castor, Tatsiana
Mia, Sobuj
Sacherer, Michael
Viereck, Robert
Borst, Oliver
Leibrock, Christina
Gawaz, Meinrad
Kuro-o, Makoto
Pilz, Stefan
Tomaschitz, Andreas
Odermatt, Alex
Pieske, Burkert
Wagner, Carsten A.
Lang, Florian
author_sort Alesutan, Ioana
collection PubMed
description Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive osteogenic transformation of vascular smooth muscle cells (VSMCs). We show that even in absence of exogenous aldosterone, silencing and pharmacological inhibition (spironolactone, eplerenone) of the mineralocorticoid receptor (MR) ameliorated phosphate-induced osteo-/chondrogenic transformation of primary human aortic smooth muscle cells (HAoSMCs). High phosphate concentrations up-regulated aldosterone synthase (CYP11B2) expression in HAoSMCs. Silencing and deficiency of CYP11B2 in VSMCs ameliorated phosphate-induced osteogenic reprogramming and calcification. Phosphate treatment was followed by nuclear export of APEX1, a CYP11B2 transcriptional repressor. APEX1 silencing up-regulated CYP11B2 expression and stimulated osteo-/chondrogenic transformation. APEX1 overexpression blunted the phosphate-induced osteo-/chondrogenic transformation and calcification of HAoSMCs. Cyp11b2 expression was higher in aortic tissue of hyperphosphatemic klotho-hypomorphic (kl/kl) mice than in wild-type mice. In adrenalectomized kl/kl mice, spironolactone treatment still significantly ameliorated aortic osteoinductive reprogramming. Our findings suggest that VSMCs express aldosterone synthase, which is up-regulated by phosphate-induced disruption of APEX1-dependent gene suppression. Vascular CYP11B2 may contribute to stimulation of VSMCs osteo-/chondrogenic transformation during hyperphosphatemia.
format Online
Article
Text
id pubmed-5435689
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-54356892017-05-18 Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells Alesutan, Ioana Voelkl, Jakob Feger, Martina Kratschmar, Denise V. Castor, Tatsiana Mia, Sobuj Sacherer, Michael Viereck, Robert Borst, Oliver Leibrock, Christina Gawaz, Meinrad Kuro-o, Makoto Pilz, Stefan Tomaschitz, Andreas Odermatt, Alex Pieske, Burkert Wagner, Carsten A. Lang, Florian Sci Rep Article Vascular calcification resulting from hyperphosphatemia is a major determinant of mortality in chronic kidney disease (CKD). Vascular calcification is driven by aldosterone-sensitive osteogenic transformation of vascular smooth muscle cells (VSMCs). We show that even in absence of exogenous aldosterone, silencing and pharmacological inhibition (spironolactone, eplerenone) of the mineralocorticoid receptor (MR) ameliorated phosphate-induced osteo-/chondrogenic transformation of primary human aortic smooth muscle cells (HAoSMCs). High phosphate concentrations up-regulated aldosterone synthase (CYP11B2) expression in HAoSMCs. Silencing and deficiency of CYP11B2 in VSMCs ameliorated phosphate-induced osteogenic reprogramming and calcification. Phosphate treatment was followed by nuclear export of APEX1, a CYP11B2 transcriptional repressor. APEX1 silencing up-regulated CYP11B2 expression and stimulated osteo-/chondrogenic transformation. APEX1 overexpression blunted the phosphate-induced osteo-/chondrogenic transformation and calcification of HAoSMCs. Cyp11b2 expression was higher in aortic tissue of hyperphosphatemic klotho-hypomorphic (kl/kl) mice than in wild-type mice. In adrenalectomized kl/kl mice, spironolactone treatment still significantly ameliorated aortic osteoinductive reprogramming. Our findings suggest that VSMCs express aldosterone synthase, which is up-regulated by phosphate-induced disruption of APEX1-dependent gene suppression. Vascular CYP11B2 may contribute to stimulation of VSMCs osteo-/chondrogenic transformation during hyperphosphatemia. Nature Publishing Group UK 2017-05-17 /pmc/articles/PMC5435689/ /pubmed/28515448 http://dx.doi.org/10.1038/s41598-017-01882-2 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Alesutan, Ioana
Voelkl, Jakob
Feger, Martina
Kratschmar, Denise V.
Castor, Tatsiana
Mia, Sobuj
Sacherer, Michael
Viereck, Robert
Borst, Oliver
Leibrock, Christina
Gawaz, Meinrad
Kuro-o, Makoto
Pilz, Stefan
Tomaschitz, Andreas
Odermatt, Alex
Pieske, Burkert
Wagner, Carsten A.
Lang, Florian
Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
title Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
title_full Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
title_fullStr Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
title_full_unstemmed Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
title_short Involvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells
title_sort involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435689/
https://www.ncbi.nlm.nih.gov/pubmed/28515448
http://dx.doi.org/10.1038/s41598-017-01882-2
work_keys_str_mv AT alesutanioana involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT voelkljakob involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT fegermartina involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT kratschmardenisev involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT castortatsiana involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT miasobuj involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT sacherermichael involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT viereckrobert involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT borstoliver involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT leibrockchristina involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT gawazmeinrad involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT kuroomakoto involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT pilzstefan involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT tomaschitzandreas involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT odermattalex involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT pieskeburkert involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT wagnercarstena involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells
AT langflorian involvementofvascularaldosteronesynthaseinphosphateinducedosteogenictransformationofvascularsmoothmusclecells